News Medical

3D bio-printed liver model and high-content imaging for evaluating the toxicity effects of compounds

The effectiveness of non-clinical drug safety predictions is enhanced by the adoption of three-dimensional (3D) cellular models. 3D bioprinting enables the generation of complex models with spatial ...
BioWorld

First-in-class thioacrylamide compound reduces hepatic fibrosis in 3D spheroid MASH model

BioWorld - Monday, January 19, 2026 Breaking News: BioWorld Science 2025 Year in Review See today's BioWorld Science Home » First-in-class thioacrylamide compound reduces hepatic fibrosis in 3D ...
BioWorld

First-in-class thioacrylamide compound reduces hepatic fibrosis in 3D spheroid MASH model

Investigators from CMR Curediab Metabolic Research GmbH recently disclosed preclinical data for a novel hepatoprotective thioacrylamide compound, HK-3, being developed for the treatment of metabolic ...